Ferrocene-Modified Phospholipid : An Innovative Precursor for Redox-Triggered Drug Delivery Vesicles Selective to Cancer Cells

Controlled payload release is one of the key elements in the creation of a reliable drug delivery system. We report the discovery of a drug delivery vessel able to transport chemotherapeutic agents to target cancer cells and selectively trigger their release using the electrochemical activity of a f...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Langmuir : the ACS journal of surfaces and colloids. - 1999. - 32(2016), 17 vom: 03. Mai, Seite 4169-78
1. Verfasser: Noyhouzer, Tomer (VerfasserIn)
Weitere Verfasser: L'Homme, Chloé, Beaulieu, Isabelle, Mazurkiewicz, Stephanie, Kuss, Sabine, Kraatz, Heinz-Bernhard, Canesi, Sylvain, Mauzeroll, Janine
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2016
Zugriff auf das übergeordnete Werk:Langmuir : the ACS journal of surfaces and colloids
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Drug Carriers Ferrous Compounds Metallocenes Phospholipids Doxorubicin 80168379AG ferrocene U96PKG90JQ
LEADER 01000naa a22002652 4500
001 NLM258517638
003 DE-627
005 20231224185158.0
007 cr uuu---uuuuu
008 231224s2016 xx |||||o 00| ||eng c
024 7 |a 10.1021/acs.langmuir.6b00511  |2 doi 
028 5 2 |a pubmed24n0861.xml 
035 |a (DE-627)NLM258517638 
035 |a (NLM)26987014 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Noyhouzer, Tomer  |e verfasserin  |4 aut 
245 1 0 |a Ferrocene-Modified Phospholipid  |b An Innovative Precursor for Redox-Triggered Drug Delivery Vesicles Selective to Cancer Cells 
264 1 |c 2016 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 29.05.2018 
500 |a Date Revised 31.03.2022 
500 |a published: Print-Electronic 
500 |a Citation Status MEDLINE 
520 |a Controlled payload release is one of the key elements in the creation of a reliable drug delivery system. We report the discovery of a drug delivery vessel able to transport chemotherapeutic agents to target cancer cells and selectively trigger their release using the electrochemical activity of a ferrocene-modified phospholipid. Supported by in vitro assays, the competitive advantages of this discovery are (i) the simple one step scalability of the synthetic process, (ii) the stable encapsulation of toxic drugs (doxorubicin) during transport, and (iii) the selective redox triggering of the liposomes to harness their cytotoxic payload at the cancer site. Specifically, the redox-modified giant unilamellar vesicle and liposomes were characterized using advanced methods such as scanning electrochemical microscopy (SECM), transmission electron microscopy (TEM), dynamic light scattering (DLS), and fluorescent imaging 
650 4 |a Journal Article 
650 4 |a Research Support, Non-U.S. Gov't 
650 7 |a Drug Carriers  |2 NLM 
650 7 |a Ferrous Compounds  |2 NLM 
650 7 |a Metallocenes  |2 NLM 
650 7 |a Phospholipids  |2 NLM 
650 7 |a Doxorubicin  |2 NLM 
650 7 |a 80168379AG  |2 NLM 
650 7 |a ferrocene  |2 NLM 
650 7 |a U96PKG90JQ  |2 NLM 
700 1 |a L'Homme, Chloé  |e verfasserin  |4 aut 
700 1 |a Beaulieu, Isabelle  |e verfasserin  |4 aut 
700 1 |a Mazurkiewicz, Stephanie  |e verfasserin  |4 aut 
700 1 |a Kuss, Sabine  |e verfasserin  |4 aut 
700 1 |a Kraatz, Heinz-Bernhard  |e verfasserin  |4 aut 
700 1 |a Canesi, Sylvain  |e verfasserin  |4 aut 
700 1 |a Mauzeroll, Janine  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Langmuir : the ACS journal of surfaces and colloids  |d 1999  |g 32(2016), 17 vom: 03. Mai, Seite 4169-78  |w (DE-627)NLM098181009  |x 1520-5827  |7 nnns 
773 1 8 |g volume:32  |g year:2016  |g number:17  |g day:03  |g month:05  |g pages:4169-78 
856 4 0 |u http://dx.doi.org/10.1021/acs.langmuir.6b00511  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_22 
912 |a GBV_ILN_350 
912 |a GBV_ILN_721 
951 |a AR 
952 |d 32  |j 2016  |e 17  |b 03  |c 05  |h 4169-78